Case number: 7:19-bk-23652 - Purdue Pharmaceuticals L.P. - New York Southern Bankruptcy Court

Case Information

Case title
Purdue Pharmaceuticals L.P.
Court
New York Southern (nysbke)
Chapter
11
Judge
Sean H. Lane
Filed
09/16/2019
Last Filing
07/03/2022
Asset
Yes
Vol
v

Docket Header

CLMAGT, JtAdm, MEGA

U.S. Bankruptcy Court
Southern District of New York (White Plains)
Bankruptcy Petition #: 19-23652-shl

Assigned to: Judge Sean H. Lane
Chapter 11
Voluntary
Asset

Date filed:

09/16/2019

Debtor Purdue Pharmaceuticals L.P. One Stamford Forum 201 Tresser Boulevard Stamford, CT 06901 FAIRFIELD-CT Tax ID / EIN: 13-4030034	represented by	Marshall Scott Huebner Davis Polk & Wardwell LLP 450 Lexington Avenue New York, NY 10017 (212) 450-4099 Fax : (212) 450-3099 Email: marshall.huebner@davispolk.com Eli J. Vonnegut Davis Polk & Wardwell LLP 450 Lexington Avenue New York, NY 10017 212-450-4331 Email: eli.vonnegut@davispolk.com
U.S. Trustee United States Trustee Office of the United States Trustee - NY Alexander Hamilton Custom House One Bowling Green, Room 534 New York, NY 10004-1408 (212) 510-0500
Claims and Noticing Agent Kroll Restructuring Administration LLC Claims Agent (Formerly Prime Clerk LLC) 55 East 52nd Street 17th Floor www.kroll.com New York, NY 10055 (212) 257-5450

Latest Dockets

Date Filed	#	Docket Text
07/03/2022	11	Certificate of Mailing Re: Notice of Case Reassignment (related document(s) (Related Doc # 10)) . Notice Date 07/03/2022. (Admin.) (Entered: 07/04/2022)
07/01/2022	10	Notice of Case Reassignment From Judge Robert D. Drain to Judge Sean H. Lane. (Gomez, Jessica). (Entered: 07/01/2022)
11/07/2019		Pending Deadlines for Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Schedules of Assets and Liabilities Terminated. (Vargas, Ana) (Entered: 11/07/2019)
11/01/2019	9	Statement of Financial Affairs - Non-Individual / Statement of Financial Affairs for Purdue Pharmaceuticals L.P. Filed by Eli J. Vonnegut on behalf of Purdue Pharmaceuticals L.P.. (Vonnegut, Eli) (Entered: 11/01/2019)
11/01/2019	8	Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Schedules of Assets and Liabilities Purdue Pharmaceuticals L.P. Filed by Eli J. Vonnegut on behalf of Purdue Pharmaceuticals L.P.. (Vonnegut, Eli) (Entered: 11/01/2019)
09/20/2019	7	Order signed on 9/18/2019 Granting Motion Extending the Time to File Schedules of Assets and Liabilities, Schedules of Current Income and Expenditures, Schedules of Executory Contracts and Unexpired Leases and Statements of Financial Affairs (Related Doc # 3) . (Vargas, Ana) (Entered: 09/20/2019)
09/20/2019		Deficiencies Set: Schedule A/B due 9/30/2019. Schedule D due 9/30/2019. Schedule E/F due 9/30/2019. Schedule G due 9/30/2019. Schedule H due 9/30/2019. Summary of Assets and Liabilities due 9/30/2019. Statement of Financial Affairs due 9/30/2019. Incomplete Filings due by 9/30/2019. (Vargas, Ana) (Entered: 09/20/2019)
09/20/2019		Claims and Noticing Agent, Prime Clerk LLC, added to the case. (Vargas, Ana) (Entered: 09/20/2019)
09/20/2019	6	Order signed on 9/18/2019 Granting Application Authorizing Retention and Appointment of Prime Clerk LLC as Claims and Noticing Agent for the Debtors (Related Doc # 4). (Vargas, Ana) (Entered: 09/20/2019)
09/20/2019		JOINTLY ADMINISTERED CHAPTER 11 CASES UNDER 19-23649-rdd Purdue Pharma L.P. (LEAD CASE): 19-23648-rdd Purdue Pharma Inc.;19-23650-rdd Purdue Transdermal Technologies L.P.;19-23651-rdd Purdue Pharma Manufacturing L.P.;19-23653-rdd Imbrium Therapeutics L.P.;19-23654-rdd Adlon Therapeutics L.P.;19-23655-rdd Greenfield BioVentures L.P.;19-23656-rdd Seven Seas Hill Corp.;19-23657-rdd Ophir Green Corp.;19-23658-rdd Purdue Pharma of Puerto Rico;19-23659-rdd Avrio Health L.P.;19-23660-rdd Purdue Pharmaceutical Products L.P.;19-23661-rdd Purdue Neuroscience Company;19-23662-rdd Nayatt Cove Lifescience Inc.;19-23663-rdd Button Land L.P.;19-23664-rdd Paul Land Inc.;19-23665-rdd Quidnick Land L.P.;19-23666-rdd Rhodes Associates L.P.;19-23667-rdd Rhodes Pharmaceuticals L.P.;19-23668-rdd Rhodes Technologies;19-23669-rdd UDF LP;19-23670-rdd SVC Pharma LP and 19-23671-rdd SVC Pharma Inc.. (Vargas, Ana) (Entered: 09/20/2019)